Solvay shares climb on better than expected Q4 results

Solvay shares climb on better than expected Q4 results
Solvay shares climb on better than expected Q4 results Copyright Thomson Reuters 2022
Copyright Thomson Reuters 2022
By Reuters
Share this articleComments
Share this articleClose Button

By Marine Strauss

BRUSSELS - Belgian chemicals group Solvay reported record profits for 2021 on Wednesday after a stronger-than-expected fourth quarter helped by higher volumes and prices, sending its shares up 3% in early trade.

The company said it expected price increases to accelerate this year as it passes higher raw material costs onto customers.

It projected earnings before interest, tax, depreciation and amortisation (EBITDA) for 2022 to grow by a mid-single digit percentage and its free cash flow to exceed 650 million euro ($736 million).

"Our Q4 results show we have the ability to act on prices (...) with a 12% rise in prices, and we're pursuing this during the 2022 first semester to overcome inflation pressures," CEO Ilham Kadri said during a press conference.

She added capital investments could reach up to 900 million euros this year, versus 736 million in 2021, and that for now the Ukraine crisis, which has triggered new Western sanctions against Russia, should have "very limited impact" on the company.

Solvay raised its dividend by 0.10 euro to 3.85 euro per share, subject to shareholder approval, after reporting an 11th consecutive quarter of positive free cash flow (FCF) generation.

"Solvay tends to guide conservatively at the start of the year so that it can progressively raise its FCF expectation as the year unfolds," ING analysts said in a note.

Solvay, which makes lithium derivatives for batteries, said fourth-quarter net turnover rose 22.1% year-on-year to 2.70 billion euros, driven primarily by automotive, electric vehicle and electronic markets, higher demand for soda ash and growth in agriculture and coating markets.

That beat a company-provided consensus of 2.52 billion euros.

Quarterly EBITDA stood at 572 million euros, also above a consensus of 517 million and a 24% increase from a year earlier.

Solvay shares were up 2.9% at 0945 GMT, outperforming a 2% rise in the Stoxx 600 Europe Chemicals.

($1 = 0.8830 euros)

Share this articleComments

You might also like